MARTA A RECASENS
Allopathic & Osteopathic Physicians|Ophthalmology GLENDALE, CA NPI 1467541508
Browse related groups: Allopathic & Osteopathic Physicians|Ophthalmology CA Astellas Pharma US Inc All categories
General Payments — all program years on this page
$2,380.09
- Category: General Payments
- Program years: PY2018–2024
- Record count: 86
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $388.61 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $388.61 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $167.09 | 3 |
| Regeneron Healthcare Solutions, Inc. | $121.83 | 1 |
| Tarsus Pharmaceuticals, Inc. | $58.81 | 2 |
| Alcon Laboratories Inc | $22.75 | 1 |
| Biogen, Inc. | $18.13 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1104823666 | Biogen, Inc. | $18.13 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110826440 | Alcon Vision LLC | $22.75 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1114144461 | Regeneron Healthcare Solutions, Inc. | $121.83 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139126872 | Tarsus Pharmaceuticals, Inc. | $28.39 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139126874 | Tarsus Pharmaceuticals, Inc. | $30.42 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139284408 | Astellas Pharma US Inc | $20.99 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139411393 | Astellas Pharma US Inc | $26.28 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139414093 | Astellas Pharma US Inc | $119.82 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.